Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

GLP-1 medications have become a popular tool for weight loss and metabolic health, but with their rise in popularity, ...

Weight-loss drugs are changing the way people grocery shop and eat. But those spending habits don't necessarily last.

GLP-1 agonists, also known as incretin mimetics ... Cleveland Clinic reports that hypoglycemia is a condition in which blood glucose levels drop below 70 mg/dL. If left untreated, it may become ...

Early results suggest that the formulas may help people drop even more weight—and could ... Ozempic and the expanding class of drugs known as GLP-1 receptor agonists (or GLP-1s) offer further ...

Expanding coverage and access to glucagon-like peptide-1 (GLP-1) medication can be beneficial for all with the cooperation of ...

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...